Exclusive: mRNA CDMO Vernal Biosciences secures $20M to continue its buildout

Ver­mont may be known for maple syrup and Ben & Jer­ry’s ice cream, but one man­u­fac­tur­er wants the Green Moun­tain State to be­come a pro­duc­er of mR­NA as well.

Ver­nal Bio­sciences, a CD­MO spe­cial­iz­ing in mR­NA and plas­mid mR­NA, told End­points News on Thurs­day it se­cured $20 mil­lion to con­tin­ue build­ing a 20,000-square-foot pro­duc­tion site in Colch­ester, VT, just north of Burling­ton. The man­u­fac­tur­er opened its doors in 2021 and has steadi­ly grown to 65 em­ploy­ees.

Endpoints News

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

The war against alcohol taxes

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning! If you aren’t already subscribed

Read More »